SCHEMBL5384858

SCHEMBL5384858

O=C(CBr)Oc1ccc2c(c1)OCO2

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 3/20 0.57
▸ MAPT P10636 2/20 0.57
▸ NPSR1 Q6W5P4 1/20 0.57
▸ LMNA P02545 4/20 0.55
▸ GAA P10253 1/20 0.55
▸ KMT2A Q03164 5/20 0.52
▸ SMN1; SMN2 Q16637 3/20 0.52
▸ ALOX15 P16050 3/20 0.52
▸ POLB P06746 2/20 0.52
▸ TP53 P04637 1/20 0.52
▸ ALDH1A1 P00352 3/20 0.51
▸ RAB9A P51151 3/20 0.49
▸ KDM4E B2RXH2 2/20 0.49
▸ NPC1 O15118 2/20 0.49
▸ PKM P14618 1/20 0.49
▸ HPGD P15428 3/20 0.49
▸ MAPK1 P28482 1/20 0.49
▸ MAOB P27338 4/20 0.49
▸ FKBP1A P62942 1/20 0.48
▸ THRB P10828 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28363239 0.85 LMNA (0.56) TSHRMAPTNPSR1LMNAGAA
SCHEMBL26250266 0.84 TSHR (0.57) TSHRMAPTNPSR1LMNAGAA
SCHEMBL1744782 0.84 RAB9A (0.66) TSHRMAPTNPSR1LMNAGAA
SCHEMBL28566805 0.83 FKBP1A (0.60) TSHRMAPTNPSR1LMNAGAA
SCHEMBL8282265 0.81 MAPT (0.58) TSHRMAPTNPSR1LMNAGAA
SCHEMBL1855445 0.81 LMNA (0.62) TSHRMAPTLMNAGAAKMT2A
SCHEMBL28564398 0.80 TSHR (0.61) TSHRMAPTNPSR1LMNAGAA
SCHEMBL2900297 0.80 LMNA (0.60) TSHRMAPTNPSR1LMNAGAA
SCHEMBL7074846 0.78 LMNA (0.60) TSHRMAPTNPSR1LMNAGAA
SCHEMBL27598271 0.78 LMNA (0.59) TSHRMAPTNPSR1LMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7208517-B1 Endothelin antagonists ABBOTT LABORTORIES (US) 2007-04-24 — — US disclosed
EP-0885215-B1 NOVEL BENZO-1,3-DIOXOLYL- AND BENZOFURANYL SUBSTITUTED PYRROLIDINE DERIVATIVES AS ENDOTHELIN ANTAGONISTS ABBOTT LAB (US) 2006-04-19 — — EP disclosed
EP-1609790-A2 Benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists Abbott Laboratories (US) 2005-12-28 — — EP disclosed
US-6462194-B1 Endothelin antagonists ABBOTT LABORATORIES 2002-10-08 — — US disclosed
EP-0776324-B1 ENDOTHELIN ANTAGONISTS ABBOTT LAB (US) 2002-06-12 — — EP disclosed
US-6380241-B1 FOR THERAPY OF CORONARY ANGINA, CEREBRAL VASOSPASM, ACUTE AND CHRONIC RENAL FAILURE, GASTRIC ULCERATION, CYCLOSPORIN-INDUCED NEPHROTOXICITY, ENDOTOXIN-INDUCED TOXICITY, ASTHMA, LPL-RELATED LIPOPROTEIN DISORDERS, PROLIFERATIVE DISEASES ABBOTT LABORATORIES 2002-04-30 — — US disclosed
EP-1186603-A2 Processes for preparing endothelin antagonists Abbott Laboratories (US) 2002-03-13 — — EP disclosed
WO-2002017912-A1 ENDOTHELIN ANTAGONISTS ABBOTT LABORATORIES (US) 2002-03-07 — — WO disclosed
EP-1003740-A2 PYRROLIDINE-3-CARBOXYLIC ACID DERIVATIVES AND THEIR USE AS ENDOTHELIN ANTAGOISTS Abbott Laboratories (US) 2000-05-31 — — EP disclosed
WO-1999006397-A2 PYRROLIDINE-3-CARBOXYLIC ACID DERIVATIVES AND THEIR USE AS ENDOTHELIN ANTAGONISTS ABBOTT LABORATORIES (US) 1999-02-11 — — WO disclosed
EP-0885215-A1 NOVEL BENZO-1,3-DIOXOLYL- AND BENZOFURANYL SUBSTITUTED PYRROLIDINE DERIVATIVES AS ENDOTHELIN ANTAGONISTS Abbott Laboratories (US) 1998-12-23 — — EP disclosed
US-5767144-A Endothelin antagonists ABBOTT LABORATORIES (US) 1998-06-16 — — US disclosed
WO-1997030045-A1 NOVEL BENZO-1,3-DIOXOLYL- AND BENZOFURANYL SUBSTITUTED PYRROLIDINE DERIVATIVES AS ENDOTHELIN ANTAGONISTS ABBOTT LABORATORIES (US) 1997-08-21 — — WO disclosed
EP-0776324-A1 ENDOTHELIN ANTAGONISTS Abbott Laboratories (US) 1997-06-04 — — EP disclosed
US-5622971-A PIPERIDINE DERIVATIVES; HYPOTENSIVE AGENTS ABBOTT LABORATORIES (US) 1997-04-22 — — US disclosed
WO-1996006095-A1 ENDOTHELIN ANTAGONISTS ABBOTT LABORATORIES (US) 1996-02-29 — — WO disclosed
Send feedback